Predictors of the plasma ratio of 2-hydroxyestrone to 16α-hyroxyestrone among pre-menopausal, nulliparous women from four ethnic groups

Carcinogenesis

Volumn 24, Issue 5, 2003, Pages 991-1005

  Jernstrom H ^e   Klug, T L ^a   Sepkovic, D W ^b,d   Bradlow, H L ^c   Narod, Steven A ^c  

^a Immuna Care Corporation   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; ESTROGEN DERIVATIVE; ETHINYLESTRADIOL; GESTAGEN; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE DERIVATIVE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ASIAN; BODY SIZE; BREAST CANCER; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN BLOOD LEVEL; ESTROGEN METABOLISM; ESTRONE BLOOD LEVEL; ETHNIC GROUP; ETHNOLOGY; FEMALE; HUMAN; INDIAN; LIFESTYLE; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUAL CYCLE; NEGRO; NULLIPARA; PAKISTAN; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; VEGETARIAN DIET;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CONTRACEPTIVE AGENTS; ESTROGEN REPLACEMENT THERAPY; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYDROXYESTRONES; MENSTRUAL CYCLE; PARITY; PREMENOPAUSE; RISK FACTORS;

EID: 0038309428     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg047     Document Type: Review

References (52)

1. Kelsey,J.L., Gammon,M.D. and John,E.M. (1993) Reproductive factors and breast cancer. Epidemiol. Rev., 15, 36-47.
2. Harris,J.R., Lippman,M.E., Veronesi,U. and Willett,W. (1993) Breast cancer. N. Engl. J. Med., 327, 319-328.
3. Thomas,H.V., Reeves,G.K. and Key,T.J. (1997) Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control, 8, 922-928.
4. The Endogenous Hormones and Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl Cancer Inst., 94, 606-616.
5. Bernstein,L. and Ross,R.K. (1993) Endogenous hormones and breast cancer risk. Epidemiol. Rev., 15, 48-65.
6. Key,T.J. and Pike,M.C. (1988) The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur. J. Cancer Clin. Oncol., 24, 29-43.
7. Kabat,G.C., Chang,C.J., Sparano,J.A., Sepkovie,D.W., Hu,X.P., Khalil,A., Rosenblatt,R. and Bradlow,H.L. (1997) Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev., 6, 505-509.
8. Bradlow,L., Telang,N.T. and Osborn,P. (1996) Estrogen metabolites as bioreactive modulators of tumor initiators and promotors. In Snyder,R. et al. (eds), Biological Reactive Intermediates. Plenum Press, New York, NY, Vol. V, pp. 285-296.
9. Schneider,J., Huh,M.M., Bradlow,H.L. and Fishman,J. (1984) Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J. Biol. Chem., 259, 4840-4845.
10. Telang,N.T., Suto,A., Wong,G.Y., Osborne,M.P. and Bradlow,H.L. (1992) Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J. Natl Cancer Inst., 84, 634-638.
11. Westerlind,K.C., Gibson,K.J. and Wolfe,P. (1999) The effect of diurnal and menstrual cyclicity and menopausal status on estrogen metabolites: implications for disease-risk assessment. Steroids, 64, 233-243.
12. Ho,G.H., Luo,X.W., Ji,C.Y., Foo,S.C. and Ng,E.H. (1998) Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. Ann. Acad. Med. Singapore, 27, 294-299.
13. Meilahn,E.N., De Stavola,B., Allen,D.S., Fentiman,I., Bradlow,H.L., Sepkovic,D.W. and Kuller,L.H. (1998) Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br. J. Cancer, 78, 1250-1255.
14. Muti,P., Bradlow,H.L., Micheli,A. et al. (2000) Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology, 11, 635-640.
15. Fowke,J.H., Qi,D., Bradlow,H.L., Shu,X.O., Gao,Y.T., Cheng,J.R., Jin,F. and Zheng,W. (2003) Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection. Steroids, 68, 65-72.
16. Ursin,G., London,S., Stanczyk,F.Z., Gentzschein,E., Paganini-Hill,A., Ross,R.K. and Pike,M.C. (1997) A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer. Environ. Health Perspect., 105, 601-605.
17. Ursin,G., London,S., Stanczyk,F.Z., Gentzschein,E., Paganini-Hill,A., Ross,R.K. and Pike,M.C. (1999) Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J. Natl Cancer Inst., 91, 1067-1072.
18. Klug,T.L., Bradlow,H.L. and Sepkovic,D.W. (1994) Monoclonal anti-body-based enzyme immunoassay for simultaneous quantitation of 2- and 16 alpha-hydroxyestrone in urine. Steroids, 59, 648-655.
19. Cauley,J.A., Zmuda,J.M., Klug,T., Ljung,B.M., Cummings,S.R. and Kuller,L.H. (2000) Estrogen metabolites and breast cancer: a prospective study. In Era of Hope Department of Defense Breast Cancer Research Program Meeting, Atlanta, GA, Vol. II, p. 471.
20. Fukuda,K., Ohta,T., Oshima,Y., Ohashi,N., Yoshikawa,M. and Yamazoe,Y. (1997) Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics, 7, 391-396.
21. Zheng,W., Jin,F., Dunning,L.A., Shu,X.O., Dai,Q., Wen,W.Q., Gao,Y.T. and Holtzman,J.L. (2001) Epidemiological study of urinary 6beta-hydroxycortisol to cortisol ratios and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 10, 237-242.
22. Ziegler,R.G., Rossi,S.C., Fears,T.R. et al. (1997) Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine. Environ. Health Perspect., 105, 607-614.
23. Bradlow,H.L., Sepkovic,D.W., Klug,T. and Osborne,M.P. (1998) Application of an improved ELISA assay to the analysis of urinary estrogen metabolites. Steroids, 63, 406-413.
24. Falk,R.T., Rossi,S.C., Fears,T.R., Sepkovic,D.W., Migella,A., Adlercreutz,H., Donaldson,J., Bradlow,H.L. and Ziegler,R.G. (2000) A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone and their ratio: reproducibility, validity and assay performance after freeze-thaw cycling and preservation by boric acid. Cancer Epidemiol. Biomarkers Prev., 9, 81-87.
25. Martini,M.C., Dancisak,B.B., Haggans,C.J., Thomas,W. and Slavin,J.L. (1999) Effects of soy intake on sex hormone metabolism in premenopausal women. Nutr. Cancer, 34, 133-139.
26. Seeger,H., Mueck,A.O. and Lippert,T.H. (2000) Effect of norethisterone acetate on estrogen metabolism in postmenopausal women [In Process Citation]. Horm. Metab. Res., 32, 436-439.
27. Preston-Martin,S., Pike,M.C., Ross,R.K., Jones,P.A. and Henderson,B.E. (1990) Increased cell division as a cause of human cancer. Cancer Res., 50, 7415-7421.
28. Russo,J., Tay,L.K. and Russo,I.H. (1982) Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res. Treat., 2, 5-73.
29. Schneider,J., Kinne,D., Fracchia,A., Pierce,V., Anderson,K.E., Bradlow,H.L. and Fishman,J. (1982) Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc. Natl Acad. Sci. USA, 79, 3047-3051.
30. Osborne,M.P., Bradlow,H.L., Wong,G.Y. and Telang,N.T. (1993) Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J. Natl Cancer Inst., 85, 1917-1920.
31. Lottering,M.L., Haag,M. and Seegers,J.C. (1992) Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res., 52, 5926-5932.
32. Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet, 347, 1713-1727.
33. Marchbanks,P.A., McDonald,J.A., Wilson,H.G. et al. (2002) Oral contraceptives and the risk of breast cancer. N. Engl. J. Med., 346, 2025-2032.
34. Grabrick,D.M., Hartmann,L.C., Cerhan,J.R. et al. (2000) Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. J. Am. Med. Assoc., 284, 1791-1798.
35. Ursin,G., London,S., Yang,D., Tseng,C.C., Pike,M.C., Bernstein,L., Stanczyk,F.Z. and Gentzschein,E. (2002) Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women. Breast Cancer Res. Treat., 72, 139-143.
36. Kuller,L.H., Matthews,K.A. and Meilhan,E.N. (2000) Estrogens and women's health: interrelation of coronary heart disease, breast cancer and osteoporosis. J. Steroid Biochem. Mol. Biol., 74, 297-309.
37. Yamazaki,H., Shaw,P.M., Guengerich,F.P. and Shimada,T. (1998) Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem. Res. Toxicol., 11, 659-665.
38. Guengerich,F.P. (1990) Metabolism of 17 alpha-ethynylestradiol in humans. Life Sci., 47, 1981-1988.
39. Nakajima,M., Yokoi,T., Mizutani,M., Kinoshita,M., Funayama,M. and Kamataki,T. (1999) Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J. Biochem. (Tokyo), 125, 803-808.
40. Jernström,H., Chu,W., Vesprini,D., Tao,Y., Majeed,N., Deal,C., Pollak,M. and Narod,S.A. (2001) Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for pre-menopausal breast cancer risk. Mol. Genet. Metab., 72, 144-154.
41. Paris,P.L., Kupelian,P.A., Hall,J.M., Williams,T.L., Levin,H., Klein,E.A., Casey,G. and Witte,J.S. (1999) Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients. Cancer Epidemiol. Biomarkers Prev., 8, 901-905.
42. International Agency for Research on Cancer (1997) Cancer Incidence in Five Continents. IARC Scientific Publications, vol. VII no. 143, i-xxxiv, 1-1240. IARC, Lyon.
43. Ziegler,R.G., Hoover,R.N., Pike,M.C. et al. (1993) Migration patterns and breast cancer risk in Asian-American women. J. Natl Cancer Inst., 85, 1819-1827.
44. Vatten,L.J., Solvoll,K. and Loken,E.B. (1990) Coffee consumption and the risk of breast cancer. A prospective study of 14,593 Norwegian women. Br. J. Cancer, 62, 267-270.
45. Ayalogu,E.O., Snelling,J., Lewis,D.F., Talwar,S., Clifford,M.N. and Ioannides,C. (1995) Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus. Biochim. Biophys. Acta, 1272, 89-94.
46. Goasduff,T., Dreano,Y., Guillois,B., Menez,J.F. and Berthou,F. (1996) Induction of liver and kidney CYP1A1/1A2 by caffeine in rat. Biochem. Pharmacol., 52, 1915-1919.
47. Rietveld,E.C., Broekman,M.M., Houben,J.J., Eskes,T.K. and van Rossum,J.M. (1984) Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids. Eur. J. Clin. Pharmacol., 26, 371-373.
48. Michnovicz,J.J., Hershcopf,R.J., Naganuma,H., Bradlow,H.L. and Fishman,J. (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N. Engl. J. Med., 315, 1305-1309.
49. Baron,J.A., La Vecchia,C. and Levi,F. (1990) The antiestrogenic effect of cigarette smoking in women. Am. J. Obstet. Gynecol., 162, 502-514.
50. Key,T.J., Pike,M.C., Brown,J.B., Hermon,C., Allen,D.S. and Wang,D.Y. (1996) Cigarette smoking and urinary oestrogen excretion in premenopausal and post-menopausal women. Br. J. Cancer, 74, 1313-1316.
51. Michnovicz,J.J., Adlercreutz,H. and Bradlow,H.L. (1997) Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. J. Natl Cancer Inst., 89, 718-723.
52. Lu,L.J., Cree,M., Josyula,S., Nagamani,M., Grady,J.J. and Anderson,K.E. (2000) Increased urinary excretion of 2-hydroxyestrone but not l6alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. Cancer Res., 60, 1299-1305.